MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 216 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $18,309,016 | +28.5% | 65,352 | +22.5% | 4.63% | -6.3% |
| Q1 2024 | $14,247,919 | +141.3% | 53,355 | +109.0% | 4.94% | +83.0% |
| Q4 2023 | $5,905,743 | +19.8% | 25,524 | -24.4% | 2.70% | +71.3% |
| Q3 2023 | $4,930,456 | -17.9% | 33,761 | +29.8% | 1.58% | -29.4% |
| Q2 2023 | $6,008,310 | +79.1% | 26,010 | +87.9% | 2.23% | +118.5% |
| Q1 2023 | $3,354,090 | -56.2% | 13,845 | -47.5% | 1.02% | -67.0% |
| Q4 2022 | $7,659,000 | – | 26,386 | – | 3.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| University of Wisconsin Foundation | 73,487 | $17,003,422 | 28.29% |
| Tao Capital Management LP | 130,529 | $30,202 | 27.63% |
| Paulson & Co. | 1,105,741 | $255,846,353 | 23.09% |
| AlpInvest Partners B.V. | 211,488 | $48,934,093 | 11.18% |
| Bain Capital Life Sciences Investors, LLC | 324,619 | $75,110,344 | 7.20% |
| Avoro Capital Advisors LLC | 1,888,888 | $437,050,905 | 6.04% |
| Propel Bio Management, LLC | 30,032 | $6,948,804 | 5.76% |
| Baker Brothers Advisors | 1,969,798 | $455,771,861 | 5.19% |
| Rosalind Advisors, Inc. | 25,000 | $5,784,500 | 4.76% |
| TCG Crossover Management, LLC | 179,917 | $41,629,195 | 4.62% |